ELV Analyst Estimates: Price Targets, Revenue, Net Income, and EBIT Forecast - Elevance Health Inc - Alpha Spread

First Time Loading...

Watchlist Manager

Watchlist

Price: 532.93 USD -0.6%

Updated:

Section:

Wall Street
Price Targets

Wall Street analysts forecast ELV stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for ELV is 617.55 USD with a low forecast of 563.58 USD and a high forecast of 698.25 USD.

ELV Lowest Forecast

Wall Street Target

ELV Average Forecast

Wall Street Target

ELV Highest Forecast

Wall Street Target

6% Upside

16% Upside

31% Upside

The latest public price target was made on Apr 19, 2024 by David Windley from Jefferies , who expects ELV stock to rise by 13% over the next 12 months. You can read more about this price target by viewing the article on StreetInsider.

Analyst	Price Target	Date	Article
David Windley Jefferies	604 USD Upside 13%	2 weeks ago Apr 19, 2024	Elevance (ELV) PT Raised to $604 at Jefferies StreetInsider
Stephen Baxter Wells Fargo	600 USD Upside 13%	2 weeks ago Apr 19, 2024	Elevance (ELV) PT Raised to $600 at Wells Fargo StreetInsider
Ben Hendrix RBC Capital	575 USD Upside 8%	2 weeks ago Apr 19, 2024	Elevance (ELV) PT Raised to $575 at RBC Capital StreetInsider
Andrew Mok Barclays	621 USD Upside 17%	2 weeks ago Apr 19, 2024	Elevance Health price target raised to $621 from $584 at Barclays TheFly
AJ Rice UBS	605 USD Upside 14%	2 weeks ago Apr 19, 2024	Elevance (ELV) PT Raised to $605 at UBS StreetInsider

Price Target	604 USD
Upside/Downside	13%

Price Target	600 USD
Upside/Downside	13%

Price Target	575 USD
Upside/Downside	8%

Price Target	621 USD
Upside/Downside	17%

Price Target	605 USD
Upside/Downside	14%

Molina Healthcare Inc

19% Upside

Progyny Inc

46% Upside

Hapvida Participacoes e Investimentos SA

45% Upside

UnitedHealth Group Inc

15% Upside

Molina Healthcare Inc

19% Upside

Progyny Inc

46% Upside

Hapvida Participacoes e Investimentos SA

45% Upside

UnitedHealth Group Inc

15% Upside

Odontoprev SA

6% Upside

Healthequity Inc

32% Upside

Revenue
Forecast

For the last 8 years the compound annual growth rate for Elevance Health Inc's revenue is 10%. The projected CAGR for the next 3 years is 5%.

10%

5%

0%

What are analyst estimates?

Net Income
Forecast

For the last 8 years the compound annual growth rate for Elevance Health Inc's net income is 11%. The projected CAGR for the next 3 years is 22%.

11%

22%

0%

What are analyst estimates?

See Also

Relative Valuation

Wall Street Estimates

Profitability Analysis

Solvency Analysis

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

According to Wall Street analysts, the average 1-year price target for ELV is 617.55 USD with a low forecast of 563.58 USD and a high forecast of 698.25 USD.

For the last 8 years the compound annual growth rate for Elevance Health Inc's revenue is 10%. The projected CAGR for the next 3 years is 5%.

For the last 8 years the compound annual growth rate for Elevance Health Inc's net income is 11%. The projected CAGR for the next 3 years is 22%.

Join more than 135,400+ value investors using Alpha Spread

Create a free account

or see our plans & pricing

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

What is Intrinsic Value? Help Center Contact Us

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.